
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs2.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A4500005DB143785BAC.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="scirep" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10616062/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616062/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Scientific Reports" /><meta name="citation_title" content="Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation" /><meta name="citation_author" content="Yumi Obata" /><meta name="citation_author_institution" content="Department of Anesthesiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan" /><meta name="citation_author" content="Atsuko Kamijo-Ikemori" /><meta name="citation_author_institution" content="Department of Anatomy, St. Marianna University School of Medicine, Kawasaki, Kanagawa Japan" /><meta name="citation_author" content="Sachi Shimmi" /><meta name="citation_author_institution" content="Department of Anesthesiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan" /><meta name="citation_author" content="Soichiro Inoue" /><meta name="citation_author_institution" content="Department of Anesthesiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan" /><meta name="citation_publication_date" content="2023" /><meta name="citation_volume" content="13" /><meta name="citation_doi" content="10.1038/s41598-023-46015-0" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10616062/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10616062/" /><meta name="citation_pmid" content="37903844" /><meta name="DC.Title" content="Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Yumi Obata" /><meta name="DC.Contributor" content="Atsuko Kamijo-Ikemori" /><meta name="DC.Contributor" content="Sachi Shimmi" /><meta name="DC.Contributor" content="Soichiro Inoue" /><meta name="DC.Date" content="2023" /><meta name="DC.Identifier" content="10.1038/s41598-023-46015-0" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation" /><meta property="og:type" content="article" /><meta property="og:description" content="This study aimed to reveal the clinical usefulness of urinary biomarkers for the early prediction of AKI onset after transcatheter aortic valve implantation (TAVI) (n&#x02009;=&#x02009;173). In this study, 22 (12.7%) patients had AKI, of which 21 had ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616062/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10616062/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Sci%20Rep%22[journal]" class="navlink">Scientific Reports</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10616062
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10616062/pdf/41598_2023_Article_46015.pdf" class="int-view">PDF (1.2M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10616062/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10616062/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10616062" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10616062%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="OG7J6y5YS6QV6EKQESerZgDXjSh2RQmEH3wLEB03zqJKK7GGU7VdtmTIy1MOEv8j">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10616062%2F&amp;text=Clinical%20usefulness%20of%20urinary%20biomarkers%20for%20early%20prediction%20of%20acute%20kidney%20injury%20in%20patients%20undergoing%20transaortic%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10616062%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616062/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10616062/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37903844/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10616062/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37903844/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10616062/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10616062/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Sci%20Rep%22[journal]" class="navlink">Scientific Reports</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10616062
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-scirep.jpg" alt="Logo of scirep" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="375,13,500,30" alt="About" title="About" href="http://www.nature.com/srep/about/index.html" ref="reftype=publisher&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="375,30,500,48" alt="Editorial Board" title="Editorial Board" href="http://www.nature.com/srep/eap-ebm/index.html#eb" ref="reftype=publisher&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="375,48,500,75" alt="For Authors" title="For Authors" href="http://www.nature.com/srep/authors/index.html" ref="reftype=publisher&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="0,0,375,75" alt="Scientific Reports" title="Scientific Reports" href="http://www.nature.com/srep/index.html" ref="reftype=publisher&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Sci Rep.</span> 2023; 13: 18569. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Oct 30. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1038%2Fs41598-023-46015-0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1038/s41598-023-46015-0</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10616062</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37903844">37903844</a></div></div></div><h1 class="content-title">Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Obata%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140696122300256" co-class="co-affbox">Yumi Obata</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kamijo-Ikemori%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140696126757008" co-class="co-affbox">Atsuko Kamijo-Ikemori</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shimmi%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140696122185760" co-class="co-affbox">Sachi Shimmi</a>,<sup>1</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Inoue%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140696124435952" co-class="co-affbox">Soichiro Inoue</a><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140696122300256"><h3 class="no_margin">Yumi Obata</h3><p><sup>1</sup>Department of Anesthesiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Obata%20Y%5BAuthor%5D">Yumi Obata</a></div></div><div id="_co_idm140696126757008"><h3 class="no_margin">Atsuko Kamijo-Ikemori</h3><p><sup>2</sup>Department of Anatomy, St. Marianna University School of Medicine, Kawasaki, Kanagawa Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kamijo-Ikemori%20A%5BAuthor%5D">Atsuko Kamijo-Ikemori</a></div></div><div id="_co_idm140696122185760"><h3 class="no_margin">Sachi Shimmi</h3><p><sup>1</sup>Department of Anesthesiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shimmi%20S%5BAuthor%5D">Sachi Shimmi</a></div></div><div id="_co_idm140696124435952"><h3 class="no_margin">Soichiro Inoue</h3><p><sup>1</sup>Department of Anesthesiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Inoue%20S%5BAuthor%5D">Soichiro Inoue</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140696206256912_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140696206256912_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140696206256912_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140696206256912_ai" style="display:none"><div class="fm-affl" id="Aff1"><sup>1</sup>Department of Anesthesiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan </div><div class="fm-affl" id="Aff2"><sup>2</sup>Department of Anatomy, St. Marianna University School of Medicine, Kawasaki, Kanagawa Japan </div><div><span class="fm-affl">Yumi Obata, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.u-annairam@atabo2y" class="oemail">pj.ca.u-annairam@atabo2y</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140696206256912_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Jul 12; Accepted 2023 Oct 26.</div></div><div class="permissions half_rhythm hide" id="idm140696206256912_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author(s) 2023</div><div class="license half_rhythm"><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Figure S1.</div><div><a href="/pmc/articles/PMC10616062/bin/41598_2023_46015_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">41598_2023_46015_MOESM1_ESM.pdf</a><span style="color:gray"> (212K)</span></div><div class="small guid">GUID: 92AD5628-856D-42D9-B133-2923482628DE</div></div></dd></dl><dl data-length="84" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>The data used to support the findings of this study are included within the article.</p></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><p id="Par1" class="p p-first-last">This study aimed to reveal the clinical usefulness of urinary biomarkers for the early prediction of AKI onset after transcatheter aortic valve implantation (TAVI) (n&#x02009;=&#x02009;173). In this study, 22 (12.7%) patients had AKI, of which 21 had mild AKI and 1 had moderate AKI. Higher levels of urinary liver-type fatty acid binding protein (L-FABP), [tissue inhibitor of metalloproteinases-2]&#x02009;&#x000d7;&#x02009;[insulin-like growth factor-binding protein 7], clusterin and urinary albumin before, after and 4&#x000a0;h after TAVI were associated with AKI onset. However, the time point of higher urinary <em>N</em>-acetyl-&#x003b2;-<span class="small-caps">d</span>-glucosaminidase levels related to AKI onset was only before TAVI. No significant differences were found in the area under the receiver-operator characteristic curves (AUC) for predicting AKI onset between urinary biomarkers before TAVI. After TAVI, the AUC (0.81) of urinary albumin was significantly higher than those of any other urinary biomarkers. The sensitivity (0.86) in urinary albumin after TAVI and specificity (0.98) in urinary L-FABP before TAVI were the highest among urinary biomarkers. In conclusion, urinary biomarkers may be clinically useful for early differentiation of patients with a higher or lower risk for AKI onset or early prediction of post-TAVI onset of AKI.</p></div><div class="sec"><strong class="kwd-title">Subject terms: </strong><span class="kwd-text">Valvular disease, Acute kidney injury</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="Par2" class="p p-first">Untreated symptomatic aortic stenosis (AS) is associated with poor prognosis and has been conventionally treated by open cardiac surgery for aortic valve replacement. Since 2002, transcatheter aortic valve implantation (TAVI) has been suggested as a less invasive procedure in patients at high risk for operative complications or death, owing to an advanced age, deteriorated functions of the heart, lung and kidney or presence of cerebrovascular disease<sup><sup><a href="#CR1" rid="CR1" class=" bibr popnode">1</a></sup></sup>. TAVI improves the circulatory dynamics via the reduction of AS and showed similar mortality to open surgery<sup><sup><a href="#CR2" rid="CR2" class=" bibr popnode">2</a></sup></sup>.</p><p id="Par3">However, acute kidney disease (AKI) is easily induced after TAVI in the high risk group and is reported to be related to the aggravation of post-TAVI mortality<sup><sup><a href="#CR3" rid="CR3" class=" bibr popnode">3</a></sup>,<sup><a href="#CR4" rid="CR4" class=" bibr popnode">4</a></sup></sup>. Post-TAVI AKI is caused by a combination of factors such as peri-procedural hypotension, decreased intravascular volume and direct nephrotoxicity of the contrast medium and specialised treatments focused on post-TAVI AKI have not been established. Therefore, at present, early diagnosis of post-TAVI AKI or early differentiation of patients at higher risk for AKI onset is performed using clinically useful biomarkers, leading to the commencement of rapid prophylactic strategies that prevent the post-TAVI onset of AKI (e.g. maintenance of adequate blood pressure, avoidance of volume depletion or minimisation of the contrast volume).</p><p id="Par4">The Valve Academic Research Consortium-2 (VARC-2) criteria using serum creatinine (SCr) or urinary volume is recommended for the diagnosis of post-TAVI AKI<sup><sup><a href="#CR5" rid="CR5" class=" bibr popnode">5</a></sup></sup>. However, SCr has a slower response after AKI onset and has lower sensitivity regarding the accurate reflection of the glomerular filtration rate in patients with poor renal function or low muscle mass<sup><sup><a href="#CR6" rid="CR6" class=" bibr popnode">6</a></sup>&#x02013;<sup><a href="#CR8" rid="CR8" class=" bibr popnode">8</a></sup></sup>. In addition, urinary volume during or after TAVI is influenced by the infusion volume or use of diuretics. Therefore, SCr and urinary volume are considered not suitable markers for early diagnosis or early differentiation of patients at higher risk of post-TAVI AKI.</p><p id="Par5" class="p p-last">Recently, several urinary new biomarkers of kidney injury, such as urinary liver-type fatty acid binding protein (L-FABP), [tissue inhibitor of metalloproteinases-2]&#x02009;&#x000d7;&#x02009;[insulin-like growth factor-binding protein 7] ([TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7]), or clusterin, have been noticed for early diagnosis of AKI. However, the clinical utility of urinary biomarkers in post-TAVI AKI has not been investigated enough. There were relatively few clinical studies to reveal the usefulness of urinary clusterin in AKI. In this study, we aimed to examine the clinical usefulness of their new biomarkers in addition to conventional markers, such as urinary albumin and urinary N-acetyl-&#x003b2;-D-glucosaminidase (NAG), in post-TAVI AKI.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Comparison of characteristics between patients with and without AKI onset</h3><p id="Par6" class="p p-first">To define AKI onset according to VARC-2 criteria, SCr was measured before operation (pre-op), immediately after operation (post-op), 4&#x000a0;h after operation (4-h post-op) and on post-operative days (PODs) 1, 2, 3, 4, 5, 6 and 7. AKI onset was observed postoperatively in 22 (12.7%) of the 173 patients enrolled in the study. Regarding AKI severity based on the VARC-2 criteria, 21 patients had mild AKI (stage 1) and 1 had moderate AKI (stage 2).</p><p id="Par7" class="p p-last">Increased body weight (<em>P</em>&#x02009;=&#x02009;0.006), decreased ejection fraction (<em>P</em>&#x02009;=&#x02009;0.011), higher coincidence of diabetes mellitus (<em>P</em>&#x02009;=&#x02009;0.049) and chronic kidney disease (CKD)(<em>P</em>&#x02009;&#x0003c;&#x02009;0.001) were significantly observed in patients with AKI (AKI group) compared with those without AKI (non-AKI group), whereas no significant differences in sex, age, body mass index, aortic mean gradient, coincidence of hypertension, chronic obstructive pulmonary disease and concomitant medications of &#x003b2;-blockers, calcium antagonists, angiotensin converted enzyme inhibitors/angiotensin II receptor blockers, statins, diuretics and non-steroidal anti-inflammatory drugs were found between AKI and non-AKI groups (Table <a href="/pmc/articles/PMC10616062/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1</span></span><span>1</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Patient characteristics.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">AKI group (n&#x02009;=&#x02009;22)</th><th align="left" rowspan="1" colspan="1">Non&#x02013;AKI group (n&#x02009;=&#x02009;151)</th><th align="left" rowspan="1" colspan="1"><em>P</em> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sex (M/F)</td><td align="left" rowspan="1" colspan="1">13/9</td><td align="left" rowspan="1" colspan="1">53/98</td><td align="center" rowspan="1" colspan="1">0.059</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">84 [80&#x02013;88]</td><td align="left" rowspan="1" colspan="1">84 [80&#x02013;86]</td><td align="center" rowspan="1" colspan="1">0.78</td></tr><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)</td><td align="left" rowspan="1" colspan="1">58 [50&#x02013;66]</td><td align="left" rowspan="1" colspan="1">51 [43&#x02013;60]</td><td align="center" rowspan="1" colspan="1">0.006*</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">24 [21&#x02013;26] </td><td align="left" rowspan="1" colspan="1">22 [20&#x02013;5] </td><td align="center" rowspan="1" colspan="1">0.066</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction (%)</td><td align="left" rowspan="1" colspan="1">60 [52&#x02013;67]</td><td align="left" rowspan="1" colspan="1">67 [59&#x02013;72]</td><td align="center" rowspan="1" colspan="1">0.011*</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean gradient (mmHg)</td><td align="left" rowspan="1" colspan="1">39 [26&#x02013;46]</td><td align="left" rowspan="1" colspan="1">38 [25&#x02013;55]</td><td align="center" rowspan="1" colspan="1">0.591</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus (%)</td><td align="left" rowspan="1" colspan="1">8 (36)</td><td align="left" rowspan="1" colspan="1">26 (17)</td><td align="center" rowspan="1" colspan="1">0.049*</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension (%)</td><td align="left" rowspan="1" colspan="1">22 (100)</td><td align="left" rowspan="1" colspan="1">124 (82)</td><td align="center" rowspan="1" colspan="1">0.131</td></tr><tr><td align="left" rowspan="1" colspan="1">Ischemic heart disease (%)</td><td align="left" rowspan="1" colspan="1">7 (32)</td><td align="left" rowspan="1" colspan="1">50 (33)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD (%)</td><td align="left" rowspan="1" colspan="1">8 (36)</td><td align="left" rowspan="1" colspan="1">36 (24)</td><td align="center" rowspan="1" colspan="1">0.425</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic kidney disease (%)</td><td align="left" rowspan="1" colspan="1">21 (95)</td><td align="left" rowspan="1" colspan="1">90 (60)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 2</td><td align="left" rowspan="1" colspan="1">1 (5)</td><td align="left" rowspan="1" colspan="1">58 (38)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 3a</td><td align="left" rowspan="1" colspan="1">6 (27)</td><td align="left" rowspan="1" colspan="1">48 (32)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 3b</td><td align="left" rowspan="1" colspan="1">5 (23)</td><td align="left" rowspan="1" colspan="1">33 (22)</td><td align="center" rowspan="1" colspan="1">0.361</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 4</td><td align="left" rowspan="1" colspan="1">6 (27)</td><td align="left" rowspan="1" colspan="1">9 (6)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 5</td><td align="left" rowspan="1" colspan="1">4 (18)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">0.82</td></tr><tr><td align="left" colspan="4" rowspan="1">Concomitant medications, n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x003b2;-blocker</td><td align="left" rowspan="1" colspan="1">7 (32)</td><td align="left" rowspan="1" colspan="1">51 (34)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ca antagonist</td><td align="left" rowspan="1" colspan="1">12 (55)</td><td align="left" rowspan="1" colspan="1">66 (44)</td><td align="center" rowspan="1" colspan="1">0.361</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;ACE inhibitor/ARB</td><td align="left" rowspan="1" colspan="1">10 (45)</td><td align="left" rowspan="1" colspan="1">67 (44)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Statin</td><td align="left" rowspan="1" colspan="1">9 (41)</td><td align="left" rowspan="1" colspan="1">59 (39)</td><td align="center" rowspan="1" colspan="1">0.82</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Diuretic</td><td align="left" rowspan="1" colspan="1">7 (32)</td><td align="left" rowspan="1" colspan="1">40 (26)</td><td align="center" rowspan="1" colspan="1">0.432</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;NSAIDs</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">1 (0.7)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative urinary L-FABP (&#x003bc;g/gCr)</td><td align="left" rowspan="1" colspan="1">5.5 [2.4&#x02013;60.9]</td><td align="left" rowspan="1" colspan="1">2.8 [1.3&#x02013;4.9]</td><td align="center" rowspan="1" colspan="1">0.005*</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7]([ng/ml]<sup>2</sup>/1000/gCr)</td><td align="left" rowspan="1" colspan="1">86.42 [38.01&#x02013;293.27]</td><td align="left" rowspan="1" colspan="1">43.48 [13.75&#x02013;99.44]</td><td align="center" rowspan="1" colspan="1">0.007*</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative urinary Clusterin (&#x003bc;g/gCr)</td><td align="left" rowspan="1" colspan="1">94.6 [33.4&#x02013;1415.2]</td><td align="left" rowspan="1" colspan="1">16.9 [7.1&#x02013;78.4]</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative urinary NAG (mg/gCr)</td><td align="left" rowspan="1" colspan="1">6.8 [4.0&#x02013;12.6]</td><td align="left" rowspan="1" colspan="1">3.5 [2.0&#x02013;6.2]</td><td align="center" rowspan="1" colspan="1">0.005*</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative urinary albumin (mg/gCr)</td><td align="left" rowspan="1" colspan="1">56 [21&#x02013;2288]</td><td align="left" rowspan="1" colspan="1">19 [11&#x02013;44]</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative sCr (mg/dl)</td><td align="left" rowspan="1" colspan="1">1.31 [1.05&#x02013;2.95]</td><td align="left" rowspan="1" colspan="1">0.84 [0.68&#x02013;1.05]</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative eGFR (ml/min)</td><td align="left" rowspan="1" colspan="1">34 [17&#x02013;47]</td><td align="left" rowspan="1" colspan="1">60 [44&#x02013;66]</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140696122020448"><a target="object" rel="noopener" href="/pmc/articles/PMC10616062/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>Data are expressed as median [interquartile range] or number (%).</p><p><em>AKI</em> acute kidney injury, <em>BMI</em> body mass index, <em>COPD</em> chronic obstructive pulmonary disease, <em>ACE inhibitor</em> angiotensin converted enzyme inhibitor, <em>ARB</em> angiotensin II receptor blocker, <em>NSAIDs</em> non-steroidal anti-inflammatory drugs, <em>L-FABP</em> liver-type fatty acid binding protein, <em>TIMP-2</em> tissue inhibitor of metalloproteinases-2, <em>IGFBP7</em> insulin-like growth factor-binding protein 7, <em>NAG</em>
<em>N</em>-acetyl-&#x003b2;-<span class="small-caps">d</span>-glucosaminidase, <em>SCr</em> serum creatinine, <em>eGFR</em> estimated glomerular filtration rate. eGFR was calculated according to the Japanese coefficient-modified Chronic Kidney Disease Epidemiology Collaboration equation: eGFR&#x02009;=&#x02009;194 &#x000d7; (creatinine)<sup>&#x02212;1.094</sup> &#x000d7; (age)<sup>&#x02212;0.287</sup> &#x000d7; (0.739 if female)<sup><sup><a href="#CR27" rid="CR27" class=" bibr popnode">27</a></sup></sup>.</p><p>*<em>P</em>&#x02009;&#x0003c;&#x02009;0.05.</p></div></div></div><div id="Sec4" class="sec"><h3 id="Sec4title">Comparison of operative and post-operative data between AKI and non-AKI groups</h3><p id="Par8" class="p p-first-last">No significant differences were noted in the kind of expansion (self-expansion or ball-on expansion), balloon aortic valvuloplasty, anaesthesia duration, operative duration, infusion fluid volume, estimated blood loss, urinary output, blood transfusion and albumin administration (Table <a href="/pmc/articles/PMC10616062/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). The volume of the contrast agent was significantly fewer in the AKI group than in the non-AKI group (<em>P</em>&#x02009;=&#x02009;0.002, Table <a href="/pmc/articles/PMC10616062/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2).</span></span><span>2</span></a>). The presence of mechanical ventilation was not significantly different between the two groups (Table <a href="/pmc/articles/PMC10616062/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). The length of hospital stay was longer in the AKI group than in the non-AKI group (<em>P</em>&#x02009;&#x0003c;&#x02009;0.001, Table <a href="/pmc/articles/PMC10616062/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2).</span></span><span>2</span></a>). One patient in the AKI group required renal replacement therapy in more than 7&#x000a0;days after TAVI, and no in-hospital deaths occurred (Table <a href="/pmc/articles/PMC10616062/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2</span></span><span>2</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p>Postoperative date and Clinical Outcomes.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">AKI group (n&#x02009;=&#x02009;22)</th><th align="left" rowspan="1" colspan="1">Non-AKI group (n&#x02009;=&#x02009;151)</th><th align="left" rowspan="1" colspan="1"><em>P</em> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Self expansion/ballon expansion</td><td align="left" rowspan="1" colspan="1">3/19</td><td align="left" rowspan="1" colspan="1">26/125</td><td align="center" rowspan="1" colspan="1">0.824</td></tr><tr><td align="left" rowspan="1" colspan="1">BAV</td><td align="left" rowspan="1" colspan="1">0.52&#x02009;&#x000b1;&#x02009;0.69</td><td align="left" rowspan="1" colspan="1">0.41&#x02009;&#x000b1;&#x02009;0.58</td><td align="center" rowspan="1" colspan="1">0.563</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of anesthesia (minutes)</td><td align="left" rowspan="1" colspan="1">137 [121&#x02013;189]</td><td align="left" rowspan="1" colspan="1">140 [117&#x02013;179]</td><td align="center" rowspan="1" colspan="1">0.923</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of surgery (minutes)</td><td align="left" rowspan="1" colspan="1">71 [61&#x02013;107]</td><td align="left" rowspan="1" colspan="1">77 [60&#x02013;102]</td><td align="center" rowspan="1" colspan="1">0.767</td></tr><tr><td align="left" rowspan="1" colspan="1">Fluids infusion (ml)</td><td align="left" rowspan="1" colspan="1">1100 [913&#x02013;1753]</td><td align="left" rowspan="1" colspan="1">1350 [1050&#x02013;1600]</td><td align="center" rowspan="1" colspan="1">0.583</td></tr><tr><td align="left" rowspan="1" colspan="1">Estimated blood loss (ml)</td><td align="left" rowspan="1" colspan="1">16 [10&#x02013;102]</td><td align="left" rowspan="1" colspan="1">10 [10&#x02013;49]</td><td align="center" rowspan="1" colspan="1">0.352</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary output (ml)</td><td align="left" rowspan="1" colspan="1">200 [138&#x02013;833]</td><td align="left" rowspan="1" colspan="1">400 [250&#x02013;620]</td><td align="center" rowspan="1" colspan="1">0.115</td></tr><tr><td align="left" rowspan="1" colspan="1">Contrast agent (ml)</td><td align="left" rowspan="1" colspan="1">47 [21&#x02013;105]</td><td align="left" rowspan="1" colspan="1">84 [66&#x02013;112]</td><td align="center" rowspan="1" colspan="1">0.002*</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood transfusion (ml)</td><td align="left" rowspan="1" colspan="1">670 [0&#x02013;1023]</td><td align="left" rowspan="1" colspan="1">530 [0&#x02013;960]</td><td align="center" rowspan="1" colspan="1">0.698</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin administration (%)<sup>&#x02020;</sup></td><td align="left" rowspan="1" colspan="1">12 (54.5)</td><td align="left" rowspan="1" colspan="1">88 (58.3)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Volume of injected albumin (ml)</td><td align="left" rowspan="1" colspan="1">250 [0&#x02013;500]</td><td align="left" rowspan="1" colspan="1">250 [0&#x02013;500]</td><td align="center" rowspan="1" colspan="1">0.763</td></tr><tr><td align="left" colspan="4" rowspan="1">Operative and postoperative details</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Mechanical ventilation, n (%)</td><td align="left" rowspan="1" colspan="1">2 (9.0)</td><td align="left" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">0.078</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Length of hospital stay (days)</td><td align="left" rowspan="1" colspan="1">23 [13&#x02013;26] </td><td align="left" rowspan="1" colspan="1">11 [9&#x02013;17] </td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;RRT required upon discharge, n (%)</td><td align="left" rowspan="1" colspan="1">1 (4.5)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">0.126</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;In-hospital death, n (%)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140696165896720"><a target="object" rel="noopener" href="/pmc/articles/PMC10616062/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p><em>AKI</em> acute kidney injury, <em>BAV</em> balloon aortic valvuloplasty<em>, RRT</em> renal replacement therapy.</p><p>*<em>P</em>&#x02009;&#x0003c;&#x02009;0.05.</p><p><sup>&#x02020;</sup>Number (%) of patient with albumin administration.</p></div></div></div><div id="Sec5" class="sec"><h3 id="Sec5title">Changes in urinary biomarkers between the AKI and non-AKI groups</h3><p id="Par9" class="p p-first">In this study, urinary L-FABP, [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7], clusterin, NAG and albumin were measured pre-operation, post-operation, 4-h post-operation and PODs 1, 2 and 3. Preoperative levels of urinary L-FABP (<em>P</em>&#x02009;=&#x02009;0.005), [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] (<em>P</em>&#x02009;=&#x02009;0.007), clusterin (<em>P</em>&#x02009;&#x0003c;&#x02009;0.001), NAG (<em>P</em>&#x02009;=&#x02009;0.005) and albumin (<em>P</em>&#x02009;&#x0003c;&#x02009;0.001) were significantly higher in the AKI group than in the non-AKI group (Table <a href="/pmc/articles/PMC10616062/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). In addition, decreased renal function was observed in the AKI group (<em>P</em>&#x02009;&#x0003c;&#x02009;0.001, Table <a href="/pmc/articles/PMC10616062/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a>).</p><p id="Par10">Changes in urinary biomarkers in the AKI and non-AKI groups are shown in Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>. In the AKI group, urinary levels of L-FABP significantly increased post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01), 4-h post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05) and on PODs 1 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05) and 3 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) compared with those pre-operation (Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). In the non-AKI group, urinary L-FABP levels significantly increased post-operation, 4-h post-operation and on PODs 1, 2 and 3 compared with those pre-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). Urinary L-FABP levels were significantly higher at all measurement points in the AKI group compared with those in the non-AKI group (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140696124414496"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10616062_41598_2023_46015_Fig1_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41598_2023_46015_Fig1_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10616062/bin/41598_2023_46015_Fig1_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140696124414496"><a target="object" rel="noopener" href="/pmc/articles/PMC10616062/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p>Box and whisker plot showing urinary liver-type fatty acid binding protein (L-FABP), urinary [TIMP-2 (tissue inhibitor of metalloproteinases-2)]&#x02009;&#x000d7;&#x02009;[IGFBP7 (insulin-like growth factor-binding protein 7)], urinary clusterin, urinary neutrophil gelatinase-associated lipocalin and urinary albumin levels measured pre-operation, immediately post-operation, 4-h post-operation and post-operative days (PODs) 1, 2 and 3 in the AKI and non-AKI groups. 4-h post-op, 4&#x000a0;h post-operative value; AKI, acute kidney injury; POD, post-operative day; Post-op, immediate post-operative value; Pre-op, preoperative value. Median and interquartile range values are shown. *<em>P</em>&#x02009;&#x0003c;&#x02009;0.05, **<em>P</em>&#x02009;&#x0003c;&#x02009;0.01 vs. level in the non-AKI group at the same time point; <sup>&#x02020;</sup><em>P</em>&#x02009;&#x0003c;&#x02009;0.05, <sup>&#x02020;&#x02020;</sup><em>P</em>&#x02009;&#x0003c;&#x02009;0.01 vs. respective preoperative level in the same (AKI) group; <sup>&#x02021;</sup><em>P</em>&#x02009;&#x0003c;&#x02009;0.05, <sup>&#x02021;&#x02021;</sup><em>P</em>&#x02009;&#x0003c;&#x02009;0.01 vs. respective preoperative level in the same (non-AKI) group.</p></div></div></div><p id="Par11">In the AKI group, urinary levels of [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] significantly increased post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05), 4-h post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05) and on PODs 2 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05) and 3 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) compared with those pre-operation (Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). In the non-AKI group, urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] levels significantly increased post-operation, 4-h post-operation and on PODs 1, 2 and 3 compared with those pre-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). Urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] levels pre-operation and on PODs 2 and 3 were significantly higher in the AKI group than in the non-AKI group (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>).</p><p id="Par12">In the AKI group, urinary levels of clusterin significantly increased post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01), 4-h post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) and on POD 1 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05) compared with those pre-operation (Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). In the non-AKI group, urinary clusterin levels significantly increased post-operation, 4-h post-operation and on PODs 1, 2 and 3 compared with those pre-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). Urinary clusterin levels were significantly higher in the AKI group than in the non-AKI group at all other points, except that on POD 3 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>).</p><p id="Par13">In the AKI group, urinary levels of NAG significantly increased on PODs 2 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) and 3 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) compared with those pre-operation (Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). In the non-AKI group, urinary NAG levels significantly increased 4-h post-operation and on PODs 1, 2 and 3 compared with those pre-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). Urinary NAG levels pre-operation and on POD 2 were significantly higher in the AKI group than in the non-AKI group (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>).</p><p id="Par14" class="p p-last">In the AKI group, urinary levels of albumin significantly increased post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) and 4-h post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) compared with those pre-operation (Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). In the non-AKI group, urinary albumin levels significantly increased post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01), 4-h post-operation (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) and on PODs 1 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01), 2 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05) and 3 (<em>P</em>&#x02009;&#x0003c;&#x02009;0.01) compared with those pre-operation (Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). Urinary albumin levels were significantly higher in the AKI group than in the non-AKI group at all measurement points (<em>P</em>&#x02009;&#x0003c;&#x02009;0.05, Fig.&#x000a0;<a href="/pmc/articles/PMC10616062/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>).</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Binomial logistic regression analysis for predicting post-TAVI onset of AKI</h3><p id="Par15" class="p p-first">In this study, to reveal whether urinary biomarkers at the early phase (pre-operation, post-operation and 4-h post-operation) were associated with AKI onset, binomial logistic regression analysis was performed using ejection fraction, diabetes mellitus and CKD as explanatory variables because these factors were significantly observed in the AKI group compared with the non-AKI group (Table <a href="/pmc/articles/PMC10616062/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3</span></span><span>3</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p>Results of binomial logistic regression analyses for AKI in the TAVI.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="left" colspan="3" rowspan="1">Unadjusted (univariate)</th><th align="left" colspan="3" rowspan="1">Adjusted for DM and CKD</th><th align="left" colspan="3" rowspan="1">Adjusted for EF and DM and CKD</th></tr><tr><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">OR</th><th align="left" rowspan="1" colspan="1">95% CI</th><th align="left" rowspan="1" colspan="1"><em>P</em> value</th><th align="left" rowspan="1" colspan="1">OR</th><th align="left" rowspan="1" colspan="1">95% CI</th><th align="left" rowspan="1" colspan="1"><em>P</em> value</th><th align="left" rowspan="1" colspan="1">OR</th><th align="left" rowspan="1" colspan="1">95% CI</th><th align="left" rowspan="1" colspan="1"><em>P</em> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ejection fraction</td><td align="left" rowspan="1" colspan="1">0.3</td><td align="left" rowspan="1" colspan="1">0.117&#x02013;0.790</td><td align="left" rowspan="1" colspan="1">0.015*</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td align="left" rowspan="1" colspan="1">2.77</td><td align="left" rowspan="1" colspan="1">1.050&#x02013;7.270</td><td align="left" rowspan="1" colspan="1">0.039*</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic kidney disease</td><td align="left" rowspan="1" colspan="1">10.5</td><td align="left" rowspan="1" colspan="1">2.380&#x02013;46.70</td><td align="left" rowspan="1" colspan="1">0.002*</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary L-FABP pre-operation</td><td align="left" rowspan="1" colspan="1">36.2</td><td align="left" rowspan="1" colspan="1">8.65&#x02013;152</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">5.25&#x02013;207</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">31.0</td><td align="left" rowspan="1" colspan="1">4.81&#x02013;200</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Post operation</td><td align="left" rowspan="1" colspan="1">5.4</td><td align="left" rowspan="1" colspan="1">2.07&#x02013;14.1</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">3.98</td><td align="left" rowspan="1" colspan="1">1.46&#x02013;10.9</td><td align="left" rowspan="1" colspan="1">0.007*</td><td align="left" rowspan="1" colspan="1">4.48</td><td align="left" rowspan="1" colspan="1">1.58&#x02013;12.7</td><td align="left" rowspan="1" colspan="1">0.005*</td></tr><tr><td align="left" rowspan="1" colspan="1">4-h post operation</td><td align="left" rowspan="1" colspan="1">5.54</td><td align="left" rowspan="1" colspan="1">2.09&#x02013;14.7</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">3.53</td><td align="left" rowspan="1" colspan="1">1.26&#x02013;9.9</td><td align="left" rowspan="1" colspan="1">0.010*</td><td align="left" rowspan="1" colspan="1">3.50</td><td align="left" rowspan="1" colspan="1">1.24&#x02013;9.93</td><td align="left" rowspan="1" colspan="1">0.018*</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary [TIMP2]&#x02009;&#x000d7;&#x02009;[IGFBP7] pre-operation</td><td align="left" rowspan="1" colspan="1">5.82</td><td align="left" rowspan="1" colspan="1">2.14&#x02013;15.8</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">6.9</td><td align="left" rowspan="1" colspan="1">2.17&#x02013;22.0</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">6.97</td><td align="left" rowspan="1" colspan="1">2.18&#x02013;22.3</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Post operation</td><td align="left" rowspan="1" colspan="1">3.57</td><td align="left" rowspan="1" colspan="1">1.15&#x02013;11.1</td><td align="left" rowspan="1" colspan="1">0.028*</td><td align="left" rowspan="1" colspan="1">3.74</td><td align="left" rowspan="1" colspan="1">1.15&#x02013;12.1</td><td align="left" rowspan="1" colspan="1">0.028*</td><td align="left" rowspan="1" colspan="1">3.65</td><td align="left" rowspan="1" colspan="1">1.12&#x02013;11.9</td><td align="left" rowspan="1" colspan="1">0.032*</td></tr><tr><td align="left" rowspan="1" colspan="1">4-h post operation</td><td align="left" rowspan="1" colspan="1">3.66</td><td align="left" rowspan="1" colspan="1">1.30&#x02013;10.3</td><td align="left" rowspan="1" colspan="1">0.014*</td><td align="left" rowspan="1" colspan="1">3.47</td><td align="left" rowspan="1" colspan="1">1.11&#x02013;10.8</td><td align="left" rowspan="1" colspan="1">0.032*</td><td align="left" rowspan="1" colspan="1">3.41</td><td align="left" rowspan="1" colspan="1">1.09&#x02013;10.7</td><td align="left" rowspan="1" colspan="1">0.035*</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary clusterin pre-operation</td><td align="left" rowspan="1" colspan="1">5.64</td><td align="left" rowspan="1" colspan="1">2.17&#x02013;16.4</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">5.47</td><td align="left" rowspan="1" colspan="1">1.88&#x02013;15.9</td><td align="left" rowspan="1" colspan="1">0.002*</td><td align="left" rowspan="1" colspan="1">5.72</td><td align="left" rowspan="1" colspan="1">1.94&#x02013;16.8</td><td align="left" rowspan="1" colspan="1">0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Post operation</td><td align="left" rowspan="1" colspan="1">9.51</td><td align="left" rowspan="1" colspan="1">3.40&#x02013;26.6</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">7.46</td><td align="left" rowspan="1" colspan="1">2.47&#x02013;22.5</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">7.66</td><td align="left" rowspan="1" colspan="1">2.49&#x02013;23.6</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">4-h post operation</td><td align="left" rowspan="1" colspan="1">11.3</td><td align="left" rowspan="1" colspan="1">3.82&#x02013;33.6</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">10.5</td><td align="left" rowspan="1" colspan="1">3.36&#x02013;32.8</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">10.1</td><td align="left" rowspan="1" colspan="1">3.22&#x02013;31.8</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary NAG pre-operation</td><td align="left" rowspan="1" colspan="1">3.97</td><td align="left" rowspan="1" colspan="1">1.46&#x02013;10.8</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">2.89</td><td align="left" rowspan="1" colspan="1">1.01&#x02013;8.21</td><td align="left" rowspan="1" colspan="1">0.047*</td><td align="left" rowspan="1" colspan="1">4.54</td><td align="left" rowspan="1" colspan="1">1.19&#x02013;17.3</td><td align="left" rowspan="1" colspan="1">0.027*</td></tr><tr><td align="left" rowspan="1" colspan="1">Post-operation</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">0.418&#x02013;2.60</td><td align="left" rowspan="1" colspan="1">0.928</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">0.28&#x02013;1.97</td><td align="left" rowspan="1" colspan="1">0.549</td><td align="left" rowspan="1" colspan="1">0.42</td><td align="left" rowspan="1" colspan="1">0.04&#x02013;3.70</td><td align="left" rowspan="1" colspan="1">0.43</td></tr><tr><td align="left" rowspan="1" colspan="1">4-h post operation</td><td align="left" rowspan="1" colspan="1">3.24</td><td align="left" rowspan="1" colspan="1">1.13&#x02013;9.31</td><td align="left" rowspan="1" colspan="1">0.029*</td><td align="left" rowspan="1" colspan="1">3.24</td><td align="left" rowspan="1" colspan="1">1.07&#x02013;9.78</td><td align="left" rowspan="1" colspan="1">0.038*</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">0.27&#x02013;2.26</td><td align="left" rowspan="1" colspan="1">0.642</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary albumin pre-operation</td><td align="left" rowspan="1" colspan="1">15.3</td><td align="left" rowspan="1" colspan="1">4.85&#x02013;48.4</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">9.64</td><td align="left" rowspan="1" colspan="1">2.65&#x02013;35.0</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">9.71</td><td align="left" rowspan="1" colspan="1">2.62&#x02013;36.0</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Post operation</td><td align="left" rowspan="1" colspan="1">11.6</td><td align="left" rowspan="1" colspan="1">3.28&#x02013;41.4</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">7.62</td><td align="left" rowspan="1" colspan="1">2.07&#x02013;28.0</td><td align="left" rowspan="1" colspan="1">0.002*</td><td align="left" rowspan="1" colspan="1">7.91</td><td align="left" rowspan="1" colspan="1">2.13&#x02013;29.4</td><td align="left" rowspan="1" colspan="1">0.002*</td></tr><tr><td align="left" rowspan="1" colspan="1">4-h post operation</td><td align="left" rowspan="1" colspan="1">9.14</td><td align="left" rowspan="1" colspan="1">3.36&#x02013;24.9</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001*</td><td align="left" rowspan="1" colspan="1">6.29</td><td align="left" rowspan="1" colspan="1">2.07&#x02013;19.1</td><td align="left" rowspan="1" colspan="1">0.001*</td><td align="left" rowspan="1" colspan="1">6.21</td><td align="left" rowspan="1" colspan="1">2.04&#x02013;18.9</td><td align="left" rowspan="1" colspan="1">0.001*</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140696136908320"><a target="object" rel="noopener" href="/pmc/articles/PMC10616062/table/Tab3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>*<em>P</em>&#x02009;&#x0003c;&#x02009;0.05.</p><p><em>AKI</em> acute kidney injury, <em>TAVI</em> Transcatheter Aortic Valve Implantation, <em>DM</em> Diabetes Mellitus, <em>CKD</em> Chronic kidney disease, <em>EF</em> Ejection fraction, <em>OR</em> odds ratio<em>, CI</em> confidence interval, <em>L-FABP</em> liver-type fatty acid binding protein, <em>TIMP-2</em> tissue inhibitor of metalloproteinases-2, <em>IGFBP7</em> insulin-like growth factor-binding protein 7, <em>NAG</em>
<em>N</em>-acetyl-&#x003b2;-<span class="small-caps">d</span>-glucosamin.</p></div></div><p id="Par16" class="p p-last">All urinary biomarkers pre-operation, post-operation and 4-h post-operation, except for urinary NAG post-operation, were significantly associated with AKI onset in the unadjusted analysis and after adjustment for diabetes mellitus and CKD (Table <a href="/pmc/articles/PMC10616062/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3).</span></span><span>3</span></a>). Furthermore, all urinary biomarkers pre-operation, post-operation and 4-h post-operation, except for urinary NAG post-operation and 4-h post-operation, independently predicted AKI onset after further adjustment for ejection fraction (Table <a href="/pmc/articles/PMC10616062/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3</span></span><span>3</span></a>).</p></div><div id="Sec7" class="sec sec-last"><h3 id="Sec7title">Receiver-operating characteristic (ROC) curves analysis of urinary biomarkers and SCr for predicting the post-TAVI onset of AKI</h3><p id="Par17" class="p p-first-last">Area under the ROC curves (AUCs) of each urinary biomarker for predicting the post-TAVI onset of AKI are shown in Table <a href="/pmc/articles/PMC10616062/table/Tab4/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4" rid-ob="ob-Tab4" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table4.</span></span><span>4</span></a>. Although no significant differences in AUC levels were found between urinary biomarkers pre-operation, the AUC level of urinary albumin (0.81) post-operation was significantly higher than any other urinary biomarkers at the same time point (Table <a href="/pmc/articles/PMC10616062/table/Tab4/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4" rid-ob="ob-Tab4" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table4).</span></span><span>4</span></a>). Furthermore, post-operation, the AUC level of urinary L-FABP (0.65) was significantly higher than that of urinary NAG (0.41) (Table <a href="/pmc/articles/PMC10616062/table/Tab4/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4" rid-ob="ob-Tab4" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table4).</span></span><span>4</span></a>). Moreover, 4-h post-operation, the AUC level of urinary clusterin (0.76) was significantly higher than that of urinary L-FABP (0.63) (Table <a href="/pmc/articles/PMC10616062/table/Tab4/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4" rid-ob="ob-Tab4" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table4).</span></span><span>4</span></a>). Each cutoff level of urinary parameters for predicting AKI onset is shown in Table <a href="/pmc/articles/PMC10616062/table/Tab5/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab5" rid-ob="ob-Tab5" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table5.</span></span><span>5</span></a>. The sensitivity (0.86) of the cutoff value (151.4&#x000a0;mg/g.cr) in urinary albumin post-operation and the specificity (0.98) of the cutoff value (35.3&#x000a0;&#x000b5;g/g.cr) in urinary L-FABP pre-operation were the highest among those of all urinary biomarkers (Table <a href="/pmc/articles/PMC10616062/table/Tab5/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab5" rid-ob="ob-Tab5" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table5</span></span><span>5</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p>AUC Time in the TAVI.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">Pre-op</th><th align="left" rowspan="1" colspan="1">Post-ope</th><th align="left" rowspan="1" colspan="1">4-h post-op</th><th align="left" rowspan="1" colspan="1">POD1</th><th align="left" rowspan="1" colspan="1">POD2</th><th align="left" rowspan="1" colspan="1">POD3</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Urinary L-FABP</td><td align="center" rowspan="1" colspan="1">0.68 (0.53&#x02013;0.83)</td><td align="center" rowspan="1" colspan="1">0.65<sup>d</sup> (0.51&#x02013;0.79)</td><td align="center" rowspan="1" colspan="1">0.63 (0.48&#x02013;0.78)</td><td align="center" rowspan="1" colspan="1">0.64 (0.48&#x02013;0.80)</td><td align="center" rowspan="1" colspan="1">0.73 (0.60&#x02013;0.85)</td><td align="center" rowspan="1" colspan="1">0.78 (0.66&#x02013;0.89)</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7]</td><td align="center" rowspan="1" colspan="1">0.68 (0.56&#x02013;0.81)</td><td align="center" rowspan="1" colspan="1">0.62 (0.48&#x02013;0.75)</td><td align="center" rowspan="1" colspan="1">0.61 (0.46&#x02013;0.75)</td><td align="center" rowspan="1" colspan="1">0.57 (0.43&#x02013;0.72)</td><td align="center" rowspan="1" colspan="1">0.66 (0.51&#x02013;0.80)</td><td align="center" rowspan="1" colspan="1">0.68 (0.52&#x02013;0.84)</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary clusterin</td><td align="center" rowspan="1" colspan="1">0.74 (0.61&#x02013;0.87)</td><td align="center" rowspan="1" colspan="1">0.67 (0.51&#x02013;0.83)</td><td align="center" rowspan="1" colspan="1">0.76<sup>a</sup> (0.61&#x02013;0.90)</td><td align="center" rowspan="1" colspan="1">0.65 (0.49&#x02013;0.81)</td><td align="center" rowspan="1" colspan="1">0.64 (0.49&#x02013;0.79)</td><td align="center" rowspan="1" colspan="1">0.63 (0.46&#x02013;0.79)</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary NAG</td><td align="center" rowspan="1" colspan="1">0.71 (0.60&#x02013;0.82)</td><td align="center" rowspan="1" colspan="1">0.41 (0.28&#x02013;0.56)</td><td align="center" rowspan="1" colspan="1">0.64 (0.52&#x02013;0.76)</td><td align="center" rowspan="1" colspan="1">0.51 (0.39&#x02013;0.64)</td><td align="center" rowspan="1" colspan="1">0.67 (0.55&#x02013;0.79)</td><td align="center" rowspan="1" colspan="1">0.59 (0.47&#x02013;0.72)</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary albumin</td><td align="center" rowspan="1" colspan="1">0.74 (0.62&#x02013;0.87)</td><td align="center" rowspan="1" colspan="1">0.81<sup>a,b,c,d</sup>
<sup>(</sup>0.69&#x02013;0.92)</td><td align="center" rowspan="1" colspan="1">0.73 (0.59&#x02013;0.87)</td><td align="center" rowspan="1" colspan="1">0.71 (0.56&#x02013;0.85)</td><td align="center" rowspan="1" colspan="1">0.72 (0.59&#x02013;0.85)</td><td align="center" rowspan="1" colspan="1">0.75 (0.63&#x02013;0.88)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140696129089376"><a target="object" rel="noopener" href="/pmc/articles/PMC10616062/table/Tab4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>Data are given as AUC (95% confidence interval). <sup>a</sup>p&#x02009;&#x0003c;&#x02009;0.05 vs. urinary L-FABP, <sup>b</sup>p&#x02009;&#x0003c;&#x02009;0.05 vs. urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7], <sup>c</sup>p&#x02009;&#x0003c;&#x02009;0.05 vs. urinary clusterin, <sup>d</sup>p&#x02009;&#x0003c;&#x02009;0.05 vs. urinary NAG.</p><p><em>AUC</em> area under the curve, <em>TAVI</em> transcatheter aortic valve implantation, <em>pre-op</em> preoperation, <em>after induction</em> after induction of anesthesia, <em>post-op</em> immediate post-operation, <em>4&#x000a0;h post-op</em> 4&#x000a0;h after surgery, <em>POD</em> post-operative day, <em>L-FABP</em> liver-type fatty acid binding protein, <em>TIMP-2</em> tissue inhibitor of metalloproteinases-2, <em>IGFBP7</em> insulin-like growth factor-binding protein 7, <em>NAG</em>
<em>N</em>-acetyl-&#x003b2;-<span class="small-caps">d</span>-glucosaminidase.</p></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p>Biomarkers levels predictive of AKI in the TAVI.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Time point</th><th align="left" rowspan="1" colspan="1">Cut-off value</th><th align="left" rowspan="1" colspan="1">Sensitivity</th><th align="left" rowspan="1" colspan="1">Specificity</th><th align="left" rowspan="1" colspan="1">PPV</th><th align="left" rowspan="1" colspan="1">NPV</th></tr></thead><tbody><tr><td align="left" colspan="6" rowspan="1">Urinary L-FABP (&#x003bc;g/gCr)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Pre-operation</td><td align="left" rowspan="1" colspan="1">35.3</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">0.98</td><td align="center" rowspan="1" colspan="1">0.75</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Post-operation</td><td align="left" rowspan="1" colspan="1">45.6</td><td align="center" rowspan="1" colspan="1">0.62</td><td align="center" rowspan="1" colspan="1">0.77</td><td align="center" rowspan="1" colspan="1">0.56</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;4&#x000a0;h post-operation</td><td align="left" rowspan="1" colspan="1">46.3</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.86</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" colspan="6" rowspan="1">Urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] ([ng/ml]<sup>2</sup>/1000/gCr)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Pre-operation</td><td align="left" rowspan="1" colspan="1">219.79</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Post-operation</td><td align="left" rowspan="1" colspan="1">91.17</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.17</td><td align="center" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;4&#x000a0;h post-operation</td><td align="left" rowspan="1" colspan="1">593.23</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.27</td><td align="center" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" colspan="6" rowspan="1">Urinary clusterin (&#x003bc;g/gCr)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Pre-operation</td><td align="left" rowspan="1" colspan="1">62.7</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.95</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Post-operation</td><td align="left" rowspan="1" colspan="1">1004.9</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">0.44</td><td align="center" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;4-h post operation</td><td align="left" rowspan="1" colspan="1">480</td><td align="center" rowspan="1" colspan="1">0.75</td><td align="center" rowspan="1" colspan="1">0.79</td><td align="center" rowspan="1" colspan="1">0.33</td><td align="center" rowspan="1" colspan="1">0.96</td></tr><tr><td align="left" colspan="6" rowspan="1">Urinary NAG (mg/gCr)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Pre-operation</td><td align="left" rowspan="1" colspan="1">4.4</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.61</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Post-operation</td><td align="left" rowspan="1" colspan="1">3.9</td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">0.49</td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;4-h post operation</td><td align="left" rowspan="1" colspan="1">6.3</td><td align="center" rowspan="1" colspan="1">0.76</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" colspan="6" rowspan="1">Urinary albumin (mg/gCr)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Pre-operation</td><td align="left" rowspan="1" colspan="1">265.9</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">0.95</td><td align="center" rowspan="1" colspan="1">0.56</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Post-operation</td><td align="left" rowspan="1" colspan="1">151.4</td><td align="center" rowspan="1" colspan="1">0.86</td><td align="center" rowspan="1" colspan="1">0.66</td><td align="center" rowspan="1" colspan="1">0.26</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;4&#x000a0;h post-operation</td><td align="left" rowspan="1" colspan="1">368.4</td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">0.41</td><td align="center" rowspan="1" colspan="1">0.93</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140696132387136"><a target="object" rel="noopener" href="/pmc/articles/PMC10616062/table/Tab5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p><em>AKI</em> acute kidney injury, <em>TAVI</em> transcatheter aortic valve implantation, <em>pre-op</em> preoperation, <em>post-op</em> immediate post-operation, <em>4&#x000a0;h post-op</em> 4&#x000a0;h after surgery, <em>POD</em> post-operative day, <em>L-FABP</em> liver-type fatty acid binding protein, <em>TIMP-2</em> tissue inhibitor of metalloproteinases-2, <em>IGFBP7</em> insulin-like growth factor-binding protein 7, <em>NAG</em>
<em>N</em>-acetyl-&#x003b2;-<span class="small-caps">d</span>-glucosaminidase.</p></div></div></div></div><div id="Sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec8title">Discussion</h2><p id="Par18" class="p p-first">This study showed that post-TAVI onset of AKI was significantly observed in older patients with decreased ejection fraction, diabetes mellitus or severe CKD. In addition, higher levels of peri-operative urinary L-FABP, [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7], clusterin, NAG and albumin at the early phase were significantly associated with the post-TAVI onset of AKI. While the AUC levels in each urinary biomarker were not significantly different pre-operation, the AUC in urinary albumin post-operation showed the highest level among all urinary biomarkers measured at the same time point. The cutoff value of urinary albumin post-operation showed the highest sensitivity, whereas that of urinary L-FABP pre-operation showed the highest specificity. Urinary biomarkers may be useful for early differentiation of patients with a higher or lower risk for AKI onset or early prediction of post-TAVI onset of AKI.</p><p id="Par19">The pathophysiology of post-TAVI AKI has not been sufficiently clarified and can be caused by various factors. Previously, the higher volume of the contrast medium injected during TAVI was reported to be a risk factor for contrast-induced nephropathy (CIN)<sup><sup><a href="#CR9" rid="CR9" class=" bibr popnode">9</a></sup></sup>. However, the present study significantly showed a lower volume of the contrast medium in the AKI group than in the non-AKI group. A recent large-scale study did not show a causal relationship between the administration of the contrast medium and AKI<sup><sup><a href="#CR10" rid="CR10" class=" bibr popnode">10</a></sup>,<sup><a href="#CR11" rid="CR11" class=" bibr popnode">11</a></sup></sup>. On the contrary, preexisting renal insufficiency is the most important risk factor for CIN<sup><sup><a href="#CR12" rid="CR12" class=" bibr popnode">12</a></sup></sup>. In the present study, impaired preoperative renal function was significantly observed in the AKI group compared with the non-AKI group, and the levels of urinary biomarkers that reflect tubular damage were significantly higher in the AKI group than in the non-AKI group before TAVI, showing that the kidneys of patients with AKI may be the most vulnerable to an even lower volume of contrast medium. Furthermore, the levels of urinary L-FABP, which reflects renal ischaemia<sup><sup><a href="#CR13" rid="CR13" class=" bibr popnode">13</a></sup>,<sup><a href="#CR14" rid="CR14" class=" bibr popnode">14</a></sup></sup>, significantly increased after TAVI than before TAVI in both AKI and non-AKI groups, and levels of urinary L-FABP remained significantly in the AKI group than in the non-AKI group during the peri-operative period of TAVI, suggesting that TAVI caused renal ischaemia and that more severe renal ischaemia may be provoked by TAVI in the kidneys of patients with AKI. A contrast medium induces tubular damage by not only direct toxic effects on tubular cells but also renal ischaemia brought by vasoconstriction<sup><sup><a href="#CR15" rid="CR15" class=" bibr popnode">15</a></sup></sup>. In this study, the contrast medium injected during TAVI may contribute to the induction of post-TAVI AKI in patients with preexisting renal dysfunction and tubular damage.</p><p id="Par20">L-FABP is localised in the cytoplasm of the proximal tubule and is excreted into the urine by ischaemic stress on the tubule before the tissue damage progresses<sup><sup><a href="#CR14" rid="CR14" class=" bibr popnode">14</a></sup></sup>. The clinical usefulness of urinary L-FABP in predicting AKI was reported in various pathophysiology<sup><sup><a href="#CR16" rid="CR16" class=" bibr popnode">16</a></sup>&#x02013;<sup><a href="#CR18" rid="CR18" class=" bibr popnode">18</a></sup></sup>, which was supported by the results of the present study. In addition, the specificity of urinary L-FABP before TAVI was the highest among those in all urinary biomarkers. Urinary L-FABP may have potential for the differentiation of patients without post-TAVI onset of AKI in addition to prediction of early post-TAVI onset of AKI.</p><p id="Par21">TIMP-2 and IGFBP7 are related to the induction of G1 cell-cycle arrest<sup><sup><a href="#CR19" rid="CR19" class=" bibr popnode">19</a></sup></sup>. Their expressions are up-regulated in proximal cells by tubular injury; thereafter, they are excreted from the tubules into the urine<sup><sup><a href="#CR19" rid="CR19" class=" bibr popnode">19</a></sup></sup>. Recently, a multicenter study reported the discovery and validation of two novel biomarkers of AKI, i.e. urinary TIMP-2 and IGFBP7<sup><sup><a href="#CR20" rid="CR20" class=" bibr popnode">20</a></sup></sup>, in patients with critical illness<sup><sup><a href="#CR19" rid="CR19" class=" bibr popnode">19</a></sup></sup>. Urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] in patients with critical illness after ICU admission was shown to be useful for predicting the development of moderate or severe AKI (KDIGO stages 2&#x02013;3) within 12&#x000a0;h<sup><sup><a href="#CR19" rid="CR19" class=" bibr popnode">19</a></sup></sup>. In the present study, urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] levels significantly increased after TAVI compared with before TAVI in both AKI and non-AKI groups and was significantly higher in the AKI group than in the non-AKI group at the late phase after TAVI. As the G1 cell-cycle arrest in the proximal tubule plays a renal protective role against AKI<sup><sup><a href="#CR21" rid="CR21" class=" bibr popnode">21</a></sup></sup>, the G1 cell-cycle arrest in the tubules was strongly induced in the kidneys of patients with post-TAVI AKI for the prevention of tubular damage. On the contrary, although higher levels of urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] after TAVI in addition to those before TAVI were associated with AKI onset, our study did not show a significant difference in urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] levels between the AKI and non-AKI groups at the early phase after TAVI. Therefore, urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] may be useful in differentiating patients at high risk for AKI before TAVI.</p><p id="Par22">Clusterin is a 5&#x02013;80&#x000a0;kDa heterodimeric glycoprotein that was reported to regulate apoptosis, lipid transport, cell interactions and complement<sup><sup><a href="#CR22" rid="CR22" class=" bibr popnode">22</a></sup></sup>. Its expression has been reported to be up-regulated in proximal tubular cells depolarised after ischaemia or renal damage and reflects tissue fibrosis<sup><sup><a href="#CR23" rid="CR23" class=" bibr popnode">23</a></sup>,<sup><a href="#CR24" rid="CR24" class=" bibr popnode">24</a></sup></sup>. Levels of urinary clusterin were significantly higher in the AKI group than in the non-AKI group at both early and late phases, increased significantly after TAVI than before TAVI in both AK and non-AKI groups, and were significantly associated with AKI onset. These results showed the possibility that urinary clusterin may be useful in differentiating patients at high risk of AKI onset before TAVI and predicting early the post-TAVI onset of AKI.</p><p id="Par23">Urinary NAG is a conventional biomarker that reflects proximal tubular damage. In this study, urinary NAG levels significantly increased from 4-h post-operation compared with pre-operation in the non-AKI group but not in the AKI group. On the contrary, significantly higher urinary NAG levels in the AKI group than in the non-AKI group were observed pre-operation but not at the early phase after TAVI. Furthermore, higher levels of NAG before TAVI were associated with AKI onset but not after TAVI. From these results, urinary NAG before TAVI may be useful in differentiating patients at high risk of AKI onset.</p><p id="Par24">Urinary albumin is widely recognized to reflect tubular injury in addition to glomerular damage<sup><sup><a href="#CR25" rid="CR25" class=" bibr popnode">25</a></sup></sup>. The higher levels of urinary albumin before TAVI were reported to be associated with not only AKI onset but also all-cause death and heart failure readmission and may be noticed for predicting the prognosis after TAVI<sup><sup><a href="#CR26" rid="CR26" class=" bibr popnode">26</a></sup></sup>. This study showed the retention of significantly higher urinary albumin levels in the AKI group than in the non-AKI group during the peri-operative period of TAVI and a significant increase in urinary albumin levels at the early phase after TAVI compared with pre-operation in both AKI and non-AKI groups. Urinary albumin levels pre-operation and early phase after TAVI were significantly associated with AKI onset. Furthermore, regarding the time point of immediately after TAVI, the AUC of urinary albumin for predicting AKI onset was the highest among AUCs of all urinary biomarkers. Tubular injury causes the impairment of peri-tubular capillary, which leads to glomerular damage that is located upstream of the peri-tubular capillary. The procedure of TAVI is considered to provoke tubular and glomerular damage. As urinary excretion of albumin is increased by glomerular and tubular damage, urinary albumin may be a prominent marker for predicting AKI onset. This study indicated that compared with other biomarkers, measuring urinary albumin immediately after TAVI is more useful for predicting AKI onset peri-operatively.</p><p id="Par25">The present study showed that the sensitivity (0.86) of the cut-off value (151.4&#x000a0;mg/g.cr) in urinary albumin post-operation and the specificity (0.98) of the cut-off value (35.3&#x000a0;&#x000b5;g/g.cr) in urinary L-FABP pre-operation were the highest among those of all urinary biomarkers. Although this point is needed to be reconfirmed in multicenter studies, measurement of urinary L-FABP before the procedure of TAVI may be useful for discrimination of patients without post-TAVI onset of AKI, whereas measurement of urinary albumin after TAVI may be superior for early predicting the post-TAVI onset of AKI.</p><p id="Par26">We considered that urinary biomarkers which reflect the pathophysiology of post-TAVI AKI may be useful for early prediction of AKI due to TAVI. Contrast medium, which induces proximal tubular injury via both direct toxic actions and renal ischemia, is an important cause for post-TAVI AKI as described above. Therefore, we selected urinary NAG which is increased by construction injury of proximal tubules, and both urinary L-FABP and clusterin which reflect proximal tubular ischemia. In addition, as renal ischemia induces cell cycle arrest and both TIMP-2 and IGFBP7 are related to the cell cycle arrest, urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] was measured. Furthermore, clinical impact of urinary albumin on the prognosis after TAVI was recently reported<sup><sup><a href="#CR26" rid="CR26" class=" bibr popnode">26</a></sup></sup> and urinary albumin was added. On the other hand, both KIM-1 and NGAL have been widely studied and are well-known tubular biomarkers. However, the relationship between urinary KIM-1 and renal ischemia was not clear. Urinary NGAL was reported to be increased by inflammation<sup><sup><a href="#CR27" rid="CR27" class=" bibr popnode">27</a></sup></sup>. We did not determine whether increased urinary NGAL levels after TAVI was due to AKI or infection brought by procedure of TAVI. Thus, urinary KIM-1 and NGAL were not evaluated in the present study.</p><p id="Par27">This study has some critical limitations. First, this was a single-centre study, and the number of patients with AKI was small, which lead to the limited number of variables included in the logistic regression analysis. Second, significant differences were found in the prevalence of CKD, each urinary biomarker level and renal function before TAVI between the AKI and non-AKI groups. The movements of each urinary biomarker after TAVI may be influenced by the presence of CKD or renal dysfunction before TAVI. Third, as albumin administration during the operation of TAVI was performed in the present study, there was a possibility that the administered albumin had an effect on urinary albumin levels. However, urinary albumin levels in the AKI group at all time points were not significantly different between the patients with and the without the albumin administration (Supplementary Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S1</a></sup>). Finally, the severity of AKI in nearly all patients with AKI was mild, and the clinical utility of urinary biomarkers for predicting the onset of moderate or severe AKI was not investigated.</p><p id="Par28" class="p p-last">In conclusion, urinary biomarkers measured in this study may be clinically useful for early differentiation of patients with a higher or lower risk for AKI onset or early prediction of post-TAVI onset of AKI. In the future, a multicenter study involving more severe AKI cases due to TAVI is needed to reveal the clinical utility and superiority of each urinary biomarker.</p></div><div id="Sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec9title">Methods</h2><p id="Par29" class="p p-first">The study protocol was approved by the Institutional Review Board of St. Marianna University School of Medicine (No. 3049) and registered in the UMIN Clinical Data Registry (ID 000020262). Written informed consent was obtained from all the enrolled patients. The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors' institutional review board or equivalent committee.</p><div id="Sec10" class="sec"><h3 id="Sec10title">Study design</h3><p id="Par30" class="p p-first">This prospective study was conducted in a university hospital. As contrast medium is one of causes which induces post-TAVI AKI, the sample size calculation was based on the previous study which showed that urinary L-FABP before injection of the contrast medium was useful for early predicting the contrast medium-induced nephropathy (CIN)<sup><sup><a href="#CR28" rid="CR28" class=" bibr popnode">28</a></sup></sup>. The mean difference of urinary L-FABP before the injection of contrast medium between the CIN and non-CIN groups was 11.1 with a larger standard deviation of 12.8. The sample size calculation (&#x003b1;&#x02009;=&#x02009;5%, power of 80%) resulted in 14 patients in the AKI group and 56 patients in the non-AKI group. In the present study, consecutive patients scheduled for TAVI (n&#x02009;=&#x02009;173) between December 2016 and June 2020 were enrolled. Each patient&#x02019;s surgeon chose between balloon expansion and self-expansion by considering the type of the aortic valve, in the absence of any concern regarding the patient&#x02019;s tolerance for study procedures. Patients undergoing dialysis or requiring emergency operation were excluded from the study.</p><p id="Par31" class="p p-last">All patients who underwent TAVI received either a balloon-expandable Edwards SAPIEN transcatheter heart valve (Edwards Lifesciences, Irvine, CA, USA) or a self-expandable Medtronic Core Valve (Medtronic Incorporation, Minneapolis, MN, USA) for clinical indications. Procedures were performed under general anesthesia with endotracheal intubation and insert transesophageal echocardiography for circulation management. TAVI devices were delivered through the femoral approach.</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">TAVI AKI study protocol</h3><div id="Sec12" class="sec sec-first-last"><p></p><h4 id="Sec12title" class="inline">Anesthesia </h4><p id="Par32" class="p p-first">No premedication was given, and general anesthesia was induced with remifentanil and propofol. Tracheal intubation was facilitated with rocuronium, general anesthesia was maintained with sevoflurane in an air&#x02013;oxygen mixture, and remifentanil, and noradrenaline was infused continuously during the operation in all patients.</p><p id="Par33" class="p p-last">If needed, nicorandil and/or carperitide were infused continuously during the operation in some groups. For transfusion, colloidal fluid, Ringer&#x02019;s acetate, maltose Ringer, concentrated red blood cell fluid, fresh-frozen plasma, and albumin were used.</p></div></div><div id="Sec13" class="sec"><h3 id="Sec13title">Sample collection</h3><p id="Par34" class="p p-first-last">Urine samples (10&#x000a0;mL) were obtained preoperatively on admission (pre-op), immediately after returning to the ward after the operation (post-op), 4&#x000a0;h after returning to the ward (4-h post-op), and POD 1, 2, and 3, respectively, for the measurement of urinary L-FABP, [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7], clusterin, NAG, and albumin. Urine samples were centrifuged at 1000&#x000d7;<em>g</em> for 5&#x000a0;min at 4&#x000a0;&#x000b0;C and stored at&#x02009;&#x02212;&#x02009;80&#x000a0;&#x000b0;C until analysis. In addition, serum samples were obtained preoperatively on admission, immediately after returning to the ward after the operation, and on PODs 1, 2, 3, 4, 5, 6, and 7 for the measurement of SCr.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Clinical monitoring of patients with TAVI</h3><p id="Par35" class="p p-first">The timing for the diagnosis of AKI was extended from 72&#x000a0;h to 7&#x000a0;days. During the first 48-h postoperative period, patients were monitored for AKI, which was defined according to the VARC-2 criteria<sup><sup><a href="#CR3" rid="CR3" class=" bibr popnode">3</a></sup></sup>. The staging of postoperative AKI was made as follows: stage 1, an increase in SCr to 150%&#x02013;199% (1.5&#x02013;1.99&#x02009;&#x000d7;&#x02009;increase compared with baseline), increase of&#x02009;&#x02265;&#x02009;0.3&#x000a0;mg/dL (&#x02265;&#x02009;26.4&#x000a0;mmol/L), or urine output&#x02009;&#x0003c;&#x02009;0.5&#x000a0;mL/kg/h for 6&#x02013;12&#x000a0;h; stage 2, an increase in SCr to 200%&#x02013;299% (2.0&#x02013;2.99&#x02009;&#x000d7;&#x02009;increase compared with baseline) or urine output&#x02009;&#x0003c;&#x02009;0.5&#x000a0;mL/kg/h for 12&#x02013;24&#x000a0;h; stage 3, induction of renal replacement therapy.</p><p id="Par36" class="p p-last">At the start of this study, the estimated glomerular filtration rate (eGFR) was also monitored, which was calculated according to the Japanese-coefficient modified Chronic Kidney Disease Epidemiology Collaboration equation<sup><sup><a href="#CR29" rid="CR29" class=" bibr popnode">29</a></sup></sup>:</p><div class="disp-formula" id="Equa"><div class="f"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2" display="block"><mrow><mtext>eGFR</mtext><mspace width="0.166667em"></mspace><mo>=</mo><mspace width="0.166667em"></mspace><mn>194</mn><mspace width="0.166667em"></mspace><mo>&#x000d7;</mo><mspace width="0.166667em"></mspace><msup><mfenced close=")" open="("><mtext>creatinine</mtext></mfenced><mrow><mo>-</mo><mn>1.094</mn></mrow></msup><mspace width="0.166667em"></mspace><mo>&#x000d7;</mo><mspace width="0.166667em"></mspace><msup><mfenced close=")" open="("><mtext>age</mtext></mfenced><mrow><mo>-</mo><mn>0.287</mn></mrow></msup><mspace width="0.166667em"></mspace><mo>&#x000d7;</mo><mspace width="0.166667em"></mspace><mfenced close=")" open="("><mrow><mn>0</mn><mo>.</mo><mrow><mtext>739 if female</mtext></mrow></mrow></mfenced><mo>.</mo></mrow></math></div></div><p></p></div><div id="Sec15" class="sec"><h3 id="Sec15title">Assay of urinary L-FABP, urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7], urinary clusterin, urinary NAG, urinary albumin, and SCr</h3><p id="Par37" class="p p-first-last">Urinary L-FABP levels were determined by latex-enhanced immunoturbidimetric assay&#x000a0;with anti-human L-FABP mouse monoclonal antibodies (Sekisui Medical, Tokyo, Japan)<sup><sup><a href="#CR30" rid="CR30" class=" bibr popnode">30</a></sup></sup>. Urinary [TIMP-2]&#x02009;&#x000d7;&#x02009;[IGFBP7] levels were determined by enzyme-linked immunosorbent assay (ELISA) with the use of the Human TIMP-2 ELISA kit (R&#x00026;D System, MN, USA) and Human IGFBP7 ELISA kit (Boster Bio, Pleasanton, USA). Urinary clusterin levels were determined by enzyme-linked immunosorbent assay (ELISA) using the Human Clusterin Quantikine ELISA kit (R&#x00026;D Systems, Minneapolis, MN, USA). Urinary NAG and albumin levels were measured by immunonephelometry. SCr was measured by an enzymatic method.</p></div><div id="Sec16" class="sec sec-last"><h3 id="Sec16title">Statistical analyses</h3><p id="Par38" class="p p-first">Study variables are expressed as median values (interquartile range [IQR]). Between-group (AKI group vs. non-AKI group) differences were analyzed by the Mann&#x02013;Whitney U test or the chi-square test, as appropriate. After the Friedman test, differences among each group were identified using Dunn&#x02019;s test. Univariate analysis was performed using the characteristics showing a significant difference between the AKI and non-AKI groups and urinary biomarkers pre-operation, post-operation, and 4-h post-operation. Following the univariate analysis, a multivariate logistic regression analysis in each urinary biomarker was performed, with the addition of ejection fraction and presence of diabetes mellitus or CKD by a forward selection method. ROCs were plotted to identify AUCs and cutoff laboratory values for predicting AKI onset.</p><p id="Par39" class="p p-last">All statistical analyses were performed with IBM SPSS Statistics version 21.0 (IBM, Tokyo, Japan), Stat Flex version 6 (Artec, Osaka, Japan), and EZR version 1.3 (Saitama Medical Center, Jichi Medical University, Saitama, Japan)<sup><sup><a href="#CR31" rid="CR31" class=" bibr popnode">31</a></sup></sup>, which is a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria).<em> P</em>&#x02009;&#x0003c;&#x02009;0.05 was considered significant for all analyses.</p></div></div><div id="sec-a.p.e" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="headless nomenu"></h2><!--/article/body/sec/--><div id="Sec17" class="sec sec-first-last"><h3 id="Sec17title">Supplementary Information</h3><p class="p p-first-last">
</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="media-a.p.e.a.b.a.a"><a href="/pmc/articles/PMC10616062/bin/41598_2023_46015_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">Supplementary Figure S1.</a><sup>(212K, pdf)</sup></div></div><p></p></div></div><div id="ack-a.q.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.q.ctitle">Acknowledgements</h2><div class="sec"><p>We thank Prof. Suzuki Manae for research content advice; Dr. Yuki Abukawa, Dr. Eriko Amano, Dr Yu Somemura and Dr. Hirotaka Okuda for sample collection; and Prof. Yoshihiro Akashi, Dr. Masaki Izumo, Dr. Ryo Kamijima, Dr. Yasuhiro Tanabe, Dr. Kazuaki Okuyama, Dr. Kaihara Toshiki and Dr. Koga Masafumi for their help in conducting the study.</p></div></div><div id="notes-a.q.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.q.dtitle">Author contributions</h2><p>Y.O., A.K.I. and S.I. contributed to the study design, study execution and manuscript preparation. S.S. contributed to the analysis of results and assistance with statistical processing. All authors have approved the final manuscript and attest to the integrity of the original data and analyses described in the paper.</p></div><div id="notes-a.q.e" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.q.etitle">Funding</h2><p>This study was supported by St. Marianna University School of Medicine On-Campus Research Grant and JSPS KAKENHI Grant No. JP 20K17848.</p></div><div id="notes-a.q.f" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.q.ftitle">Data availability</h2><p>The data used to support the findings of this study are included within the article.</p></div><div id="FPar1" class="tsec sec"><h2 class="head no_bottom_margin" id="FPar1title">Competing interests</h2><p id="Par40">The authors declare no competing interests.</p></div><div id="fn-group-a.q.a" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.q.atitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.q.a.a"><p class="p p-first"><strong>Publisher's note</strong></p><p class="p p-last">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></p></div></div><div id="sec-a.q.b" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="sec-a.q.btitle">Supplementary Information</h2><!--/article/back/sec/--><p class="p p-first-last">The online version contains supplementary material available at 10.1038/s41598-023-46015-0.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Cribier A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. <span><span class="ref-journal">Circulation. </span>2002;<span class="ref-vol">106</span>:3006–3008. doi: 10.1161/01.cir.0000047200.36165.b8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12473543" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2F01.cir.0000047200.36165.b8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Percutaneous+transcatheter+implantation+of+an+aortic+valve+prosthesis+for+calcific+aortic+stenosis:+First+human+case+description&amp;author=A+Cribier&amp;volume=106&amp;publication_year=2002&amp;pages=3006-3008&amp;pmid=12473543&amp;doi=10.1161/01.cir.0000047200.36165.b8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Leon MB, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. <span><span class="ref-journal">N. Engl. J. Med. </span>2010;<span class="ref-vol">363</span>:1597–1607. doi: 10.1056/NEJMoa1008232.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20961243" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1056%2FNEJMoa1008232" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med.&amp;title=Transcatheter+aortic-valve+implantation+for+aortic+stenosis+in+patients+who+cannot+undergo+surgery&amp;author=MB+Leon&amp;volume=363&amp;publication_year=2010&amp;pages=1597-1607&amp;pmid=20961243&amp;doi=10.1056/NEJMoa1008232&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Barbash IM, et al. Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. <span><span class="ref-journal">Am. Heart J. </span>2012;<span class="ref-vol">163</span>:1031–1036. doi: 10.1016/j.ahj.2012.01.009.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22709757" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ahj.2012.01.009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+Heart+J.&amp;title=Incidence+and+predictors+of+acute+kidney+injury+after+transcatheter+aortic+valve+replacement&amp;author=IM+Barbash&amp;volume=163&amp;publication_year=2012&amp;pages=1031-1036&amp;pmid=22709757&amp;doi=10.1016/j.ahj.2012.01.009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Elhmidi Y, et al. Acute kidney injury after transcatheter aortic valve implantation: Incidence, predictors and impact on mortality. <span><span class="ref-journal">Arch. Cardiovasc. Dis. </span>2014;<span class="ref-vol">107</span>:133–139. doi: 10.1016/j.acvd.2014.01.002.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24556191" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.acvd.2014.01.002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch.+Cardiovasc.+Dis.&amp;title=Acute+kidney+injury+after+transcatheter+aortic+valve+implantation:+Incidence,+predictors+and+impact+on+mortality&amp;author=Y+Elhmidi&amp;volume=107&amp;publication_year=2014&amp;pages=133-139&amp;pmid=24556191&amp;doi=10.1016/j.acvd.2014.01.002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Kappetein AP, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. <span><span class="ref-journal">J. Thorac. Cardiovasc. Surg. </span>2013;<span class="ref-vol">145</span>:6–23. doi: 10.1016/j.jtcvs.2012.09.002.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23084102" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jtcvs.2012.09.002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Thorac.+Cardiovasc.+Surg.&amp;title=Updated+standardized+endpoint+definitions+for+transcatheter+aortic+valve+implantation:+The+Valve+Academic+Research+Consortium-2+consensus+document&amp;author=AP+Kappetein&amp;volume=145&amp;publication_year=2013&amp;pages=6-23&amp;pmid=23084102&amp;doi=10.1016/j.jtcvs.2012.09.002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Bellomo R, Kellum JA, Ronco C. Acute kidney injury. <span><span class="ref-journal">Lancet. </span>2012;<span class="ref-vol">380</span>:756–766. doi: 10.1016/S0140-6736(11)61454-2.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22617274" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0140-6736(11)61454-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Acute+kidney+injury&amp;author=R+Bellomo&amp;author=JA+Kellum&amp;author=C+Ronco&amp;volume=380&amp;publication_year=2012&amp;pages=756-766&amp;pmid=22617274&amp;doi=10.1016/S0140-6736(11)61454-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Doi K, et al. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. <span><span class="ref-journal">J. Am. Soc. Nephrol. </span>2009;<span class="ref-vol">20</span>:1217–1221. doi: 10.1681/ASN.2008060617.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2689892/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19389851" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1681%2FASN.2008060617" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Soc.+Nephrol.&amp;title=Reduced+production+of+creatinine+limits+its+use+as+marker+of+kidney+injury+in+sepsis&amp;author=K+Doi&amp;volume=20&amp;publication_year=2009&amp;pages=1217-1221&amp;pmid=19389851&amp;doi=10.1681/ASN.2008060617&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Grootendorst DC, et al. The MDRD formula does not reflect GFR in ESRD patients. <span><span class="ref-journal">Nephrol. Dial. Transplant. </span>2011;<span class="ref-vol">26</span>:1932–1937. doi: 10.1093/ndt/gfq667.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21056944" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fndt%2Fgfq667" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol.+Dial.+Transplant&amp;title=The+MDRD+formula+does+not+reflect+GFR+in+ESRD+patients&amp;author=DC+Grootendorst&amp;volume=26&amp;publication_year=2011&amp;pages=1932-1937&amp;pmid=21056944&amp;doi=10.1093/ndt/gfq667&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="mixed-citation">Van Linden A. <em>et al</em>. Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients. <em>Eur. J. Cardiothorac. Surg</em>. <strong>39</strong>, 835&#x02013;842. 10.1016/j.ejcts.2010.11.034 (2011). [<a href="https://pubmed.ncbi.nlm.nih.gov/21186126" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Ehmann MR, et al. Renal outcomes following intravenous contrast administration in patients with acute kidney injury: A multi-site retrospective propensity-adjusted analysis. <span><span class="ref-journal">Intensive Care Med. </span>2023;<span class="ref-vol">49</span>:205–215. doi: 10.1007/s00134-022-06966-w.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36715705" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00134-022-06966-w" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med.&amp;title=Renal+outcomes+following+intravenous+contrast+administration+in+patients+with+acute+kidney+injury:+A+multi-site+retrospective+propensity-adjusted+analysis&amp;author=MR+Ehmann&amp;volume=49&amp;publication_year=2023&amp;pages=205-215&amp;pmid=36715705&amp;doi=10.1007/s00134-022-06966-w&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Lee YC, Hsieh CC, Chang TT, Li CY. Contrast-induced acute kidney injury among patients with chronic kidney disease undergoing imaging studies: A meta-analysis. <span><span class="ref-journal">AJR Am. J. Roentgenol. </span>2019;<span class="ref-vol">213</span>:728–735. doi: 10.2214/AJR.19.21309.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31386574" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2214%2FAJR.19.21309" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AJR+Am.+J.+Roentgenol.&amp;title=Contrast-induced+acute+kidney+injury+among+patients+with+chronic+kidney+disease+undergoing+imaging+studies:+A+meta-analysis&amp;author=YC+Lee&amp;author=CC+Hsieh&amp;author=TT+Chang&amp;author=CY+Li&amp;volume=213&amp;publication_year=2019&amp;pages=728-735&amp;pmid=31386574&amp;doi=10.2214/AJR.19.21309&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Abe M, Kimura T, Morimoto T, Furukawa Y, Kita T. Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients. <span><span class="ref-journal">Circ. J. </span>2009;<span class="ref-vol">73</span>:1518–1522. doi: 10.1253/circj.cj-08-0784.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19531900" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1253%2Fcircj.cj-08-0784" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circ.+J.&amp;title=Incidence+of+and+risk+factors+for+contrast-induced+nephropathy+after+cardiac+catheterization+in+Japanese+patients&amp;author=M+Abe&amp;author=T+Kimura&amp;author=T+Morimoto&amp;author=Y+Furukawa&amp;author=T+Kita&amp;volume=73&amp;publication_year=2009&amp;pages=1518-1522&amp;pmid=19531900&amp;doi=10.1253/circj.cj-08-0784&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="mixed-citation">Tanabe, J., Ouchi, T., Watanabe, N. &#x00026; Tanabe, K. Wild-type transthyretin cardiac amyloidosis diagnosed in a patient in his 50s. <em>BMJ Case Rep</em>. <strong>13</strong>. 10.1136/bcr-2020-236656 (2020). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7328889/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32606107" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Yamamoto T, et al. Renal L-type fatty acid-binding protein in acute ischemic injury. <span><span class="ref-journal">J. Am. Soc. Nephrol. </span>2007;<span class="ref-vol">18</span>:2894–2902. doi: 10.1681/ASN.2007010097.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17942962" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1681%2FASN.2007010097" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Soc.+Nephrol.&amp;title=Renal+L-type+fatty+acid-binding+protein+in+acute+ischemic+injury&amp;author=T+Yamamoto&amp;volume=18&amp;publication_year=2007&amp;pages=2894-2902&amp;pmid=17942962&amp;doi=10.1681/ASN.2007010097&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: Risk factors, pathophysiology and treatment. <span><span class="ref-journal">Nat. Rev. Nephrol. </span>2017;<span class="ref-vol">13</span>:697–711. doi: 10.1038/nrneph.2017.119.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28869251" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrneph.2017.119" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Nephrol.&amp;title=Cardiac+surgery-associated+acute+kidney+injury:+Risk+factors,+pathophysiology+and+treatment&amp;author=Y+Wang&amp;author=R+Bellomo&amp;volume=13&amp;publication_year=2017&amp;pages=697-711&amp;pmid=28869251&amp;doi=10.1038/nrneph.2017.119&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Hishikari K, et al. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of acute kidney injury in patients with acute decompensated heart failure. <span><span class="ref-journal">Cardiorenal Med. </span>2017;<span class="ref-vol">7</span>:267–275. doi: 10.1159/000476002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5662955/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29118765" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1159%2F000476002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiorenal+Med.&amp;title=Urinary+liver-type+fatty+acid-binding+protein+level+as+a+predictive+biomarker+of+acute+kidney+injury+in+patients+with+acute+decompensated+heart+failure&amp;author=K+Hishikari&amp;volume=7&amp;publication_year=2017&amp;pages=267-275&amp;pmid=29118765&amp;doi=10.1159/000476002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Obata Y, et al. Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair. <span><span class="ref-journal">J. Anesth. </span>2016;<span class="ref-vol">30</span>:89–99. doi: 10.1007/s00540-015-2095-8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4750552/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26585768" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00540-015-2095-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Anesth.&amp;title=Clinical+usefulness+of+urinary+liver-type+fatty-acid-binding+protein+as+a+perioperative+marker+of+acute+kidney+injury+in+patients+undergoing+endovascular+or+open-abdominal+aortic+aneurysm+repair&amp;author=Y+Obata&amp;volume=30&amp;publication_year=2016&amp;pages=89-99&amp;pmid=26585768&amp;doi=10.1007/s00540-015-2095-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Okuda H, Obata Y, Kamijo-Ikemori A, Inoue S. Quantitative and qualitative analyses of urinary L-FABP for predicting acute kidney injury after emergency laparotomy. <span><span class="ref-journal">J. Anesth. </span>2022;<span class="ref-vol">36</span>:38–45. doi: 10.1007/s00540-021-03003-w.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34716487" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00540-021-03003-w" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Anesth.&amp;title=Quantitative+and+qualitative+analyses+of+urinary+L-FABP+for+predicting+acute+kidney+injury+after+emergency+laparotomy&amp;author=H+Okuda&amp;author=Y+Obata&amp;author=A+Kamijo-Ikemori&amp;author=S+Inoue&amp;volume=36&amp;publication_year=2022&amp;pages=38-45&amp;pmid=34716487&amp;doi=10.1007/s00540-021-03003-w&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Kashani K, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. <span><span class="ref-journal">Crit. Care. </span>2013;<span class="ref-vol">17</span>:R25. doi: 10.1186/cc12503.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4057242/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23388612" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fcc12503" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit.+Care&amp;title=Discovery+and+validation+of+cell+cycle+arrest+biomarkers+in+human+acute+kidney+injury&amp;author=K+Kashani&amp;volume=17&amp;publication_year=2013&amp;pages=R25&amp;pmid=23388612&amp;doi=10.1186/cc12503&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Meersch M, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. <span><span class="ref-journal">Intensive Care Med. </span>2017;<span class="ref-vol">43</span>:1551–1561. doi: 10.1007/s00134-016-4670-3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5633630/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28110412" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00134-016-4670-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med.&amp;title=Prevention+of+cardiac+surgery-associated+AKI+by+implementing+the+KDIGO+guidelines+in+high+risk+patients+identified+by+biomarkers:+The+PrevAKI+randomized+controlled+trial&amp;author=M+Meersch&amp;volume=43&amp;publication_year=2017&amp;pages=1551-1561&amp;pmid=28110412&amp;doi=10.1007/s00134-016-4670-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">DiRocco DP, et al. CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury. <span><span class="ref-journal">Am. J. Physiol. Renal Physiol. </span>2014;<span class="ref-vol">306</span>:F379–388. doi: 10.1152/ajprenal.00475.2013.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3920026/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24338822" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1152%2Fajprenal.00475.2013" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Physiol.+Renal+Physiol.&amp;title=CDK4/6+inhibition+induces+epithelial+cell+cycle+arrest+and+ameliorates+acute+kidney+injury&amp;author=DP+DiRocco&amp;volume=306&amp;publication_year=2014&amp;pages=F379-388&amp;pmid=24338822&amp;doi=10.1152/ajprenal.00475.2013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Rosenberg ME, Silkensen J. Clusterin: Physiologic and pathophysiologic considerations. <span><span class="ref-journal">Int. J. Biochem. Cell Biol. </span>1995;<span class="ref-vol">27</span>:633–645. doi: 10.1016/1357-2725(95)00027-m.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7648419" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F1357-2725(95)00027-m" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Biochem.+Cell+Biol.&amp;title=Clusterin:+Physiologic+and+pathophysiologic+considerations&amp;author=ME+Rosenberg&amp;author=J+Silkensen&amp;volume=27&amp;publication_year=1995&amp;pages=633-645&amp;pmid=7648419&amp;doi=10.1016/1357-2725(95)00027-m&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Guo J, et al. Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury. <span><span class="ref-journal">BMC Nephrol. </span>2016;<span class="ref-vol">17</span>:133. doi: 10.1186/s12882-016-0348-x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5028988/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27649757" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs12882-016-0348-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Nephrol.&amp;title=Relationship+of+clusterin+with+renal+inflammation+and+fibrosis+after+the+recovery+phase+of+ischemia-reperfusion+injury&amp;author=J+Guo&amp;volume=17&amp;publication_year=2016&amp;pages=133&amp;pmid=27649757&amp;doi=10.1186/s12882-016-0348-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Kim SS, et al. Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus. <span><span class="ref-journal">Clin. Endocrinol. (Oxf.) </span>2017;<span class="ref-vol">87</span>:156–164. doi: 10.1111/cen.13360.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5511063/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28434209" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fcen.13360" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Endocrinol.+(Oxf.)&amp;title=Urine+clusterin/apolipoprotein+J+is+linked+to+tubular+damage+and+renal+outcomes+in+patients+with+type+2+diabetes+mellitus&amp;author=SS+Kim&amp;volume=87&amp;publication_year=2017&amp;pages=156-164&amp;pmid=28434209&amp;doi=10.1111/cen.13360&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Yu Y, et al. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. <span><span class="ref-journal">Nat. Biotechnol. </span>2010;<span class="ref-vol">28</span>:470–477. doi: 10.1038/nbt.1624.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20458317" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnbt.1624" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Biotechnol.&amp;title=Urinary+biomarkers+trefoil+factor+3+and+albumin+enable+early+detection+of+kidney+tubular+injury&amp;author=Y+Yu&amp;volume=28&amp;publication_year=2010&amp;pages=470-477&amp;pmid=20458317&amp;doi=10.1038/nbt.1624&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Tobe A, et al. Impact of albuminuria on the prognosis after transcatheter aortic valve implantation. <span><span class="ref-journal">Am. J. Cardiol. </span>2023;<span class="ref-vol">186</span>:156–162. doi: 10.1016/j.amjcard.2022.09.020.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36280473" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.amjcard.2022.09.020" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Cardiol.&amp;title=Impact+of+albuminuria+on+the+prognosis+after+transcatheter+aortic+valve+implantation&amp;author=A+Tobe&amp;volume=186&amp;publication_year=2023&amp;pages=156-162&amp;pmid=36280473&amp;doi=10.1016/j.amjcard.2022.09.020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="mixed-citation">Asada, T. <em>et al</em>. Impact of clinical context on acute kidney injury biomarker performances: Differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein. <em>Sci. Rep</em>. <strong>6</strong>, 33077. 10.1038/srep33077 (2016). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5015077/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27605390" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Nakamura T, et al. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. <span><span class="ref-journal">Am. J. Kidney Dis. </span>2006;<span class="ref-vol">47</span>:432–444. doi: 10.1053/j.ajkd.2005.11.006.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16490622" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1053%2Fj.ajkd.2005.11.006" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Kidney+Dis.&amp;title=Urinary+excretion+of+liver-type+fatty+acid-binding+protein+in+contrast+medium-induced+nephropathy&amp;author=T+Nakamura&amp;volume=47&amp;publication_year=2006&amp;pages=432-444&amp;doi=10.1053/j.ajkd.2005.11.006&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Matsuo S, et al. Revised equations for estimated GFR from serum creatinine in Japan. <span><span class="ref-journal">Am. J. Kidney Dis. </span>2009;<span class="ref-vol">53</span>:982–992. doi: 10.1053/j.ajkd.2008.12.034.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19339088" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1053%2Fj.ajkd.2008.12.034" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Kidney+Dis.&amp;title=Revised+equations+for+estimated+GFR+from+serum+creatinine+in+Japan&amp;author=S+Matsuo&amp;volume=53&amp;publication_year=2009&amp;pages=982-992&amp;pmid=19339088&amp;doi=10.1053/j.ajkd.2008.12.034&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Kamijo-Ikemori A, et al. Clinical utility of urinary liver-type fatty acid binding protein measured by latex-enhanced turbidimetric immunoassay in chronic kidney disease. <span><span class="ref-journal">Clin. Chem. Lab Med. </span>2016;<span class="ref-vol">54</span>:1645–1654. doi: 10.1515/cclm-2015-1084.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26943609" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1515%2Fcclm-2015-1084" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Chem.+Lab+Med.&amp;title=Clinical+utility+of+urinary+liver-type+fatty+acid+binding+protein+measured+by+latex-enhanced+turbidimetric+immunoassay+in+chronic+kidney+disease&amp;author=A+Kamijo-Ikemori&amp;volume=54&amp;publication_year=2016&amp;pages=1645-1654&amp;pmid=26943609&amp;doi=10.1515/cclm-2015-1084&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. <span><span class="ref-journal">Bone Marrow Transplant. </span>2013;<span class="ref-vol">48</span>:452–458. doi: 10.1038/bmt.2012.244.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3590441/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23208313" ref="reftype=pubmed&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fbmt.2012.244" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bone+Marrow+Transplant&amp;title=Investigation+of+the+freely+available+easy-to-use+software+'EZR'+for+medical+statistics&amp;author=Y+Kanda&amp;volume=48&amp;publication_year=2013&amp;pages=452-458&amp;pmid=23208313&amp;doi=10.1038/bmt.2012.244&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10616062&amp;issue-id=425018&amp;journal-id=1579&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Scientific Reports</span> are provided here courtesy of <strong>Nature Publishing Group</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10616062/pdf/41598_2023_Article_46015.pdf" class="int-view">PDF (1.2M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10616062/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10616062/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10616062" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10616062%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="OG7J6y5YS6QV6EKQESerZgDXjSh2RQmEH3wLEB03zqJKK7GGU7VdtmTIy1MOEv8j">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10616062%2F&amp;text=Clinical%20usefulness%20of%20urinary%20biomarkers%20for%20early%20prediction%20of%20acute%20kidney%20injury%20in%20patients%20undergoing%20transaortic%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10616062%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616062/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10616062/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37903844/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10616062/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37903844/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10616062/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10616062/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10616062/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
